Evidence map›Paper›PMID 31844253›Full record

ArticleCell death and differentiation2020

ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics.

He Liu, Zhaoyue He, Nina Germič, Hyrijie Ademi, Živa Frangež, Andrea Felser, Shuang Peng, Carsten Riether, Valentin Djonov, Jean-Marc Nuoffer and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Functional Relationships between L1CAM, LC3, ATG12, and Aβ.International journal of molecular sciences · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

He Liu *Institute of Pharmacology, University of Bern, Inselspital, CH-3010, Bern, Switzerland.
Zhaoyue He *Institute of Pharmacology, University of Bern, Inselspital, CH-3010, Bern, Switzerland.
Nina GermičInstitute of Pharmacology, University of Bern, Inselspital, CH-3010, Bern, Switzerland.
Hyrijie AdemiInstitute of Pharmacology, University of Bern, Inselspital, CH-3010, Bern, Switzerland.
Živa FrangežInstitute of Pharmacology, University of Bern, Inselspital, CH-3010, Bern, Switzerland.
Andrea FelserUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
Shuang PengInstitute of Pharmacology, University of Bern, Inselspital, CH-3010, Bern, Switzerland.
Carsten RietherDepartment of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.ORCID http://orcid.org/0000-0001-7512-513X
Valentin DjonovInstitute of Anatomy, University of Bern, CH-3012, Bern, Switzerland.
Jean-Marc NuofferUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
Cédric BovetUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
Irena Mlinarič-RaščanUniversity of Ljubljana, Faculty of Pharmacy, SL-1000, Ljubljana, Slovenia.
Inti ZlobecInstitute of Pathology, University of Bern, CH-3008, Bern, Switzerland.
Martin FiedlerUniversity Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
Aurel PerrenInstitute of Pathology, University of Bern, CH-3008, Bern, Switzerland.ORCID http://orcid.org/0000-0002-6819-6092
Hans-Uwe SimonInstitute of Pharmacology, University of Bern, Inselspital, CH-3010, Bern, Switzerland. hus@pki.unibe.ch.ORCID http://orcid.org/0000-0002-9404-7736
University of Bern · CHSechenov University · RUUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In contrast to the "Warburg effect" or aerobic glycolysis earlier generalized as a phenomenon in cancer cells, more and more recent evidence indicates that functional mitochondria are pivotal for ensuring the energy supply of cancer cells. Here, we report that cancer cells with reduced autophagy-related protein 12 (ATG12) expression undergo an oncotic cell death, a phenotype distinct from that seen in ATG5-deficient cells described before. In addition, using untargeted metabolomics with ATG12-deficient cancer cells, we observed a global reduction in cellular bioenergetic pathways, such as β-oxidation (FAO), glycolysis, and tricarboxylic acid cycle activity, as well as a decrease in mitochondrial respiration as monitored with Seahorse experiments. Analyzing the biogenesis of mitochondria by quantifying mitochondrial DNA content together with several mitochondrion-localizing proteins indicated a reduction in mitochondrial biogenesis in ATG12-deficient cancer cells, which also showed reduced hexokinase II expression and the upregulation of uncoupling protein 2. ATG12, which we observed in normal cells to be partially localized in mitochondria, is upregulated in multiple types of solid tumors in comparison with normal tissues. Strikingly, mouse xenografts of ATG12-deficient cells grew significantly slower as compared with vector control cells. Collectively, our work has revealed a previously unreported role for ATG12 in regulating mitochondrial biogenesis and cellular energy metabolism and points up an essential role for mitochondria as a failsafe mechanism in the growth and survival of glycolysis-dependent cancer cells. Inducing oncosis by imposing an ATG12 deficiency in solid tumors might represent an anticancer therapy preferable to conventional caspase-dependent apoptosis that often leads to undesirable consequences, such as incomplete cancer cell killing and a silencing of the host immune system.

Indexed as

AnimalsAutophagy-Related Protein 12Cell Line, TumorEnergy MetabolismGlycolysisHumansMiceMice, Inbred NODMice, SCIDMitochondriaNeoplasmsATG12 protein, humanAutophagy-Related Protein 12

Identifiers

PMID31844253
PMCPMC7244572
OpenAlexW2940735425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.